Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment
Main Authors: | Gangat, N, Patnaik, M M, Begna, K, Al-Kali, A, Litzow, M R, Ketterling, R P, Hanson, C A, Pardanani, A D, Tefferi, A |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855255/ |
Similar Items
-
Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
by: Pardanani, A, et al.
Published: (2015) -
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes
by: Pardanani, A, et al.
Published: (2012) -
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
by: Barraco, D, et al.
Published: (2016) -
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
by: Barraco, D, et al.
Published: (2016) -
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
by: Pardanani, A, et al.
Published: (2013)